Reuters logo
BRIEF-Theravance Biopharma reports qtrly loss per share $1.36
2017年2月27日 / 晚上9点33分 / 7 个月前

BRIEF-Theravance Biopharma reports qtrly loss per share $1.36

Feb 27 (Reuters) - Theravance Biopharma Inc

* Theravance Biopharma, Inc. reports fourth quarter and full year 2016 financial results and provides business update

* Q4 revenue $5.7 million versus I/B/E/S view $4.9 million

* Theravance Biopharma Inc - Anticipate full year 2017 operating loss, excluding share-based compensation, will be in range of $195.0 to $205.0 million

* Qtrly loss per share $1.36

* Q4 earnings per share view $-1.05 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below